4 ms·

> The possible risks of these vaccines are not being ignored Several years after initial outbreak, I wonder if continuation of the emergency use authorization

> The possible risks of these vaccines are not being ignored Several years after initial outbreak, I wonder if continuation of the emergency use authorization can be justified, or if it continues because it allows the medical establishment to not be liable for realized risks. Possible risks don't matter to manufacturers, because nobody is liable for injury.

klyrs 4y ago
The observed risk of naive infection continues to outweigh the possible risks of the vaccine. The long-term effects of both are still being studied. In fact, several treatments that were granted emergency use authorization have been revoked [1], because on the balance, they were not effective enough to justify the authorization. [1] https://en.wikipedia.org/wiki/Emergency_Use_Authorization#Use_during_pandemics https://en.wikipedia.org/wiki/Emergency_Use_Authorization#Us...
vgt 4y ago
What do you mean by "continuation of emergency use authentication??". They're all fully approved by the FDA by now [0]: https://www.hopkinsmedicine.org/health/conditions-and-diseases/coronavirus/full-fda-approval-of-a-covid-19-vaccine-what-you-should-know https://www.hopkinsmedicine.org/health/conditions-and-diseas...
- bassrattle 4y ago
  As I understand, Pfizer got Comirnaty approved, but virtually no one has been administered Comirnaty still.
- landemva 4y ago
  FDA continues to re-issue EUA, first issued under Trump, which shields liability and allows use without long-term studies of effectiveness. Scroll down this URL and read some of the EUAs. https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization https://www.fda.gov/emergency-preparedness-and-response/mcm-... "On October 19, 2022, having concluded that revising this EUA is appropriate to protect the public health or safety under section 564(g)(2) of the Act, FDA is reissuing the September 12, 2022 letter of authorization in its entirety to authorize the use of Novavax COVID‑19 Vaccine"

klyrs 4y ago

The observed risk of naive infection continues to outweigh the possible risks of the vaccine. The long-term effects of both are still being studied. In fact, several treatments that were granted emergency use authorization have been revoked [1], because on the balance, they were not effective enough to justify the authorization. [1] https://en.wikipedia.org/wiki/Emergency_Use_Authorization#Use_during_pandemics https://en.wikipedia.org/wiki/Emergency_Use_Authorization#Us...

vgt 4y ago

What do you mean by "continuation of emergency use authentication??". They're all fully approved by the FDA by now [0]: https://www.hopkinsmedicine.org/health/conditions-and-diseases/coronavirus/full-fda-approval-of-a-covid-19-vaccine-what-you-should-know https://www.hopkinsmedicine.org/health/conditions-and-diseas...

bassrattle 4y ago
As I understand, Pfizer got Comirnaty approved, but virtually no one has been administered Comirnaty still.
landemva 4y ago
FDA continues to re-issue EUA, first issued under Trump, which shields liability and allows use without long-term studies of effectiveness. Scroll down this URL and read some of the EUAs. https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization https://www.fda.gov/emergency-preparedness-and-response/mcm-... "On October 19, 2022, having concluded that revising this EUA is appropriate to protect the public health or safety under section 564(g)(2) of the Act, FDA is reissuing the September 12, 2022 letter of authorization in its entirety to authorize the use of Novavax COVID‑19 Vaccine"